Generation of a novel immunodeficient mouse model of Mucopolysaccharidosis type IIIA to test human stem cell-based therapies.

MLA

Mandolfo, Oriana, et al. “Generation of a Novel Immunodeficient Mouse Model of Mucopolysaccharidosis Type IIIA to Test Human Stem Cell-Based Therapies.” Molecular Genetics and Metabolism, vol. 143, no. 1–2, Sept. 2024, p. 108533. EBSCOhost, https://doi.org/10.1016/j.ymgme.2024.108533.

APA

Mandolfo, O., Parker, H., Usman, A., Learmonth, Y. I., Holley, R. J., MacDonald, A., McKay, T., & Bigger, B. (2024). Generation of a novel immunodeficient mouse model of Mucopolysaccharidosis type IIIA to test human stem cell-based therapies. Molecular Genetics and Metabolism, 143(1–2), 108533. https://doi.org/10.1016/j.ymgme.2024.108533

Chicago

Mandolfo, Oriana, Helen Parker, Asma’u Usman, Yuko Ishikawa Learmonth, Rebecca J Holley, Andrew MacDonald, Tristan McKay, and Brian Bigger. 2024. “Generation of a Novel Immunodeficient Mouse Model of Mucopolysaccharidosis Type IIIA to Test Human Stem Cell-Based Therapies.” Molecular Genetics and Metabolism 143 (1–2): 108533. doi:10.1016/j.ymgme.2024.108533.